Biocryst Pharmaceuticals Inc
BCRX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000882796
No open-market purchases or sales by Biocryst Pharmaceuticals Inc insiders were filed in the last 90 days; 319 institutions reported holding it in 13F filings for Q2 2026, worth $2.61B in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Biocryst Pharmaceuticals Inc as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 230
- −2 vs. Q3 2022
- Shares held
- 156.9M
- +8.32M (+5.6%) vs. Q3 2022
- Total value
- $1.80B
- −$71.4M (−3.8%) vs. Q3 2022
- New holders
- 34
- 93 more added
- Sold out
- 36
- 61 more reduced
2 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BCRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 319 | $2.61B |
| Q1 2026 | 303 | $2.37B |
| Q4 2025 | 273 | $1.66B |
| Q3 2025 | 286 | $1.47B |
| Q2 2025 | 294 | $1.77B |
| Q1 2025 | 274 | $1.32B |
| Q4 2024 | 258 | $1.26B |
| Q3 2024 | 257 | $1.32B |
| Q2 2024 | 242 | $1.08B |
| Q1 2024 | 238 | $915.0M |
| Q4 2023 | 236 | $1.06B |
| Q3 2023 | 233 | $1.24B |
| Q2 2023 | 236 | $1.23B |
| Q1 2023 | 242 | $1.42B |
| Q4 2022 | 230 | $1.80B |
| Q3 2022 | 234 | $1.87B |
| Q2 2022 | 221 | $1.61B |
| Q1 2022 | 233 | $2.07B |
| Q4 2021 | 206 | $1.63B |
| Q3 2021 | 197 | $1.48B |
| Q2 2021 | 195 | $1.65B |
| Q1 2021 | 191 | $1.06B |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Biocryst Pharmaceuticals Inc; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Jacobs Levy Equity Management, Inc | 1,468,106 | $16.9M | 0.11% | +1,051,580+252.5% | Added |
| Alkeon Capital Management LLC | 1,485,817 | $17.1M | 0.13% | +20,532+1.4% | Added |
| Nuveen Asset Management, LLC | 1,605,694 | $18.4M | 0.01% | −297,127−15.6% | Reduced |
| Segall Bryant & Hamill, LLC | 1,668,999 | $19.2M | 0.21% | −12,190−0.7% | Reduced |
| GW&K Investment Management, LLC | 1,727,087 | $19.8M | 0.20% | +309,947+21.9% | Added |
| Northern Trust Corp | 1,747,460 | $20.1M | 0.00% | −49,331−2.7% | Reduced |
| Stifel Financial Corp | 1,844,074 | $21.2M | 0.03% | −2,100−0.1% | Reduced |
| First Manhattan Co | 1,868,672 | $21.5M | 0.08% | +63,600+3.5% | Added |
| Rock Springs Capital Management LP | 1,890,737 | $21.7M | 0.52% | +178,230+10.4% | Added |
| Two Sigma Advisers, LP | 1,970,912 | $22.6M | 0.06% | −44,900−2.2% | Reduced |
| Point72 Asset Management, L.P. | 1,988,627 | $22.8M | 0.09% | +1,988,627 | New |
| Janus Henderson Group PLC | 2,050,026 | $23.5M | 0.02% | +2,014,048+5,598.0% | Added |
| Woodline Partners LP | 2,070,983 | $23.8M | 0.33% | +2,070,983 | New |
| PFM Health Sciences, LP | 2,162,411 | $24.8M | 1.05% | 00.0% | Unchanged |
| Victory Capital Management Inc | 2,533,584 | $29.1M | 0.03% | −986,647−28.0% | Reduced |
| Fairmount Funds Management LLC | 2,543,107 | $29.2M | 4.63% | 00.0% | Unchanged |
| Assenagon Asset Management S.A. | 2,590,392 | $29.7M | 0.12% | −25,765−1.0% | Reduced |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 2,862,387 | $32.9M | 0.12% | +581,434+25.5% | Added |
| Artisan Partners Limited Partnership | 2,878,427 | $33.0M | 0.06% | +228,811+8.6% | Added |
| Geode Capital Management, LLC | 3,466,550 | $39.8M | 0.01% | +100,706+3.0% | Added |
| RP Management, LLC | 3,846,154 | $44.2M | 52.00% | 00.0% | Unchanged |
| Fisher Asset Management, LLC | 4,431,114 | $50.9M | 0.03% | −732,731−14.2% | Reduced |
| Pictet Asset Management SA | 5,285,348 | $60.7M | 0.09% | +471,576+9.8% | Added |
| FMR LLC | 7,120,995 | $81.7M | 0.01% | +1,413,928+24.8% | Added |
| Avoro Capital Advisors LLC | 9,050,000 | $103.9M | 1.55% | 00.0% | Unchanged |
| State Street Corp | 11,126,861 | $127.7M | 0.01% | +1,722,614+18.3% | Added |
| Baker Bros. Advisors LP | 12,710,818 | $145.9M | 0.88% | 00.0% | Unchanged |
| Vanguard Group Inc | 14,204,395 | $163.1M | 0.00% | +365,783+2.6% | Added |
| BlackRock Inc. | 14,918,955 | $171.3M | 0.01% | +1,143,960+8.3% | Added |
| Tfo-TDC, LLC | 2 | – | – | +2 | New |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −1,223,721−100.0% | Sold out |
| MPM Oncology Impact Management LP | 0 | $0 | 0.00% | −605,663−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −565,380−100.0% | Sold out |
| Kynam Capital Management, LP | 0 | $0 | 0.00% | −435,117−100.0% | Sold out |
| Lisanti Capital Growth, LLC | 0 | $0 | 0.00% | −305,095−100.0% | Sold out |
| Gilder Gagnon Howe & Co LLC | 0 | $0 | 0.00% | −303,642−100.0% | Sold out |
| Twinbeech Capital LP | 0 | $0 | 0.00% | −250,517−100.0% | Sold out |
| Velan Capital Investment Management LP | 0 | $0 | 0.00% | −225,000−100.0% | Sold out |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −216,327−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −92,879−100.0% | Sold out |
| Bender Robert & Associates | 0 | $0 | 0.00% | −68,600−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −61,459−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −54,467−100.0% | Sold out |
| AlphaCrest Capital Management LLC | 0 | $0 | 0.00% | −49,026−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −40,454−100.0% | Sold out |
| Edge Wealth Management LLC | 0 | $0 | 0.00% | −35,000−100.0% | Sold out |
| Financial Advocates Investment Management | 0 | $0 | 0.00% | −12,708−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −29,226−100.0% | Sold out |
| HighVista Strategies LLC | 0 | $0 | 0.00% | −25,837−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −24,972−100.0% | Sold out |
| Gotham Asset Management, LLC | 0 | $0 | 0.00% | −24,034−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −23,803−100.0% | Sold out |
| Seven Eight Capital, LP | 0 | $0 | 0.00% | −20,330−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −19,854−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −19,121−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −18,428−100.0% | Sold out |
| HAP Trading, LLC | 0 | $0 | 0.00% | −17,834−100.0% | Sold out |
| Los Angeles Capital Management LLC | 0 | $0 | 0.00% | −14,285−100.0% | Sold out |
| Quantitative Investment Management, LLC | 0 | $0 | 0.00% | −10,677−100.0% | Sold out |
| Amundi | 0 | $0 | 0.00% | −7,471−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −6,732−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −5,019−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −1,500−100.0% | Sold out |
| Bogart Wealth, LLC | 0 | $0 | 0.00% | −250−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −14−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| American Portfolios Advisors | – | – | – | – | Not filed |
| Pacific Center for Financial Services | – | – | – | – | Not filed |